Clinical Trials · NCT07570810
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Enrollment
- 30
- Start date
- Jun 2026
- Locations
- See registry
- Primary endpoint
- Percentage change in body weight relative to baseline